The companys SilverHawk system is a minimally invasive method of removing the obstructive plaqueĪnd restoring blood flow to the legs and feet. Date of Earliest Transaction (Month/Day/Year) 5.

FOXH (Last) (First) (Middle) C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD 3. These blockages can result in severe pain for patients and very limited Issuer Name and Ticker or Trading Symbol FOXHOLLOW TECHNOLOGIES, INC. PAD results from plaque that accumulates in the arteries and blocksīlood flow in the legs. are thought to suffer from PAD, with 2.5 million patients currently diagnosed. An estimated 12 million people in the U.S.

Date of Earliest Transaction (Month/Day/Year) (Street) REDWOOD CITY, CA 94063 (City) (State) (Zip) 4. Issuer Name and Ticker or Trading Symbol FOXHOLLOW TECHNOLOGIES, INC. Treatment of peripheral artery disease (PAD). John Bush Simpson, Trustee of the Rita Lynn Simpson Annuity Trust dated October 20, 2004: 2. Myrtle Potter will continue as the companys lead independent director and that Dr. Simpson will also remain as a member of the board of directors.įoxHollow Technologies, Inc., develops and markets minimally invasive plaque excision devices for the I have incredible confidence in the employees at FoxHollowĪnd I look forward to continuing the pursuit of our mission to eradicate vascular disease., he continued. These successes reflect the dedication of our employees and theĬompanys strong management team, led by Ron Steckel, our chief operating officer, Duke Rohlen, our president of strategic operations, and Matt Ferguson, our chief financial officer. Inc., is proceeding ahead of schedule, Dr. Simpson said. In addition, we have realized great progress with our product development and clinical trial programs, and our collaboration with Merck & Co., We have experienced increasing adoption of the SilverHawk in the treatment of patients suffering from PeripheralĪrtery Disease (PAD) and are saving lives and improving the quality of life for these patients. The company has achieved important milestones in key areas of the company. We believe that FoxHollow will benefit from his continued leadership, she added.ĭelighted to have been chosen for this position by the board. (Name of Issuer) Common Stock (Title of Class of Securities) 35166A 10 3 (CUSIP Number) Decem(Date of Event Which Requires Filing of this Statement) Check the. Under Johns leadership this year, the company has continued its aggressive market building activities, accelerated its clinical and research and development initiatives and Myrtle Potter, the companys lead independent director. ∺fter undergoing an extensive search process and interviewing a number of highly qualified candidates, we determined that John is the best person to lead FoxHollow through its next phase of growth, said (FOXH), which manufactures and markets the SilverHawk PlaqueĮxcision System, today announced that its board of directors has named Dr. John Simpson as permanent chief executive officer of the company.ĭr. Simpson, the founder of the company, has been serving as interim chief executive officer following the retirement of Robert W. (REDWOOD CITY, CA,) June 5, 2006≿oxHollow Technologies, Inc.

Rita lynn simpson bloomberg foxhollow